Compounds > ciprofloxacin

ciprofloxacin and olaquindox

ciprofloxacin has been researched along with olaquindox in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hooper, DC; Jacoby, GA; Kim, EC; Kim, HB; Park, CH; Wang, M1
Chen, S; Chen, Z; Deng, Y; Huang, X; Liu, JH; Liu, Y; Sun, Y; Tian, W; Wu, C; Zeng, Z; Zhao, J1
Cho, JH; Jeong, SH; Song, YK1
Bonomo, RA; Chen, L; Coakley, P; Hujer, AM; Kreiswirth, BN; Marshall, SH; Paterson, DL; Perez, F; Rather, PN; Rudin, SD; Toltzis, P; van Duin, D1

Other Studies

4 other study(ies) available for ciprofloxacin and olaquindox

ArticleYear
oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Proteins; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Humans; Klebsiella pneumoniae; Plasmids; Sequence Analysis, DNA

2009
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Quinolones

2010
Risk assessment of ciprofloxacin, flavomycin, olaquindox and colistin sulfate based on microbiological impact on human gut biota.
    Regulatory toxicology and pharmacology : RTP, 2009, Volume: 53, Issue:3

    Topics: Adult; Bacteria, Aerobic; Bacteria, Anaerobic; Bambermycins; Ciprofloxacin; Colistin; Feces; Female; Humans; Intestines; Microbial Sensitivity Tests; No-Observed-Adverse-Effect Level; Quinoxalines; Risk Assessment; Veterinary Drugs; Young Adult

2009
OqxAB, a quinolone and olaquindox efflux pump, is widely distributed among multidrug-resistant Klebsiella pneumoniae isolates of human origin.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9

    Topics: Americas; Animals; Anti-Bacterial Agents; Asia; Australia; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Genes, MDR; Humans; Klebsiella Infections; Klebsiella pneumoniae; Quinolones; Quinoxalines; Swine; Swine Diseases

2013